Pathogenic mechanisms in proliferative vitreoretinopathy.

Landmarks in the development of treatment of retinal detachment include the recognition of the significance of retinal breaks that resulted in the distinction between rhegmatogenous retinal detachment (RRD) and exudative retinal detachment, the development of indirect ophthalmoscopy and scleral depression that allow better visualization of the peripheral area of the retina and better identification of retinal breaks, the recognition of the need to seal all retinal breaks, and the realization that vitreous traction is the major underlying cause of retinal tears and RRD. Scleral buckling procedures combine retinopexy to provide a scar around retinal breaks to seal them and scleral indentation to neutralize vitreous traction; they provided the first effective treatment of RRD. As surgeons gained experience with scleral buckling, they became aware that some RRDs, particularly those with fixed folds and/or a funnel configuration, often could not be repaired using this approach. It was thought that excessive vitreous traction was at fault, and the condition was called "massive vitreous retraction."

[1]  P. Campochiaro,et al.  Intravitreal chemotactic and mitogenic activity. Implication of blood-retinal barrier breakdown. , 1986, Archives of ophthalmology.

[2]  Don H. Anderson,et al.  Intraretinal proliferation induced by retinal detachment. , 1991, Investigative ophthalmology & visual science.

[3]  P. Campochiaro,et al.  The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy. , 1995, Ophthalmology.

[4]  P. Campochiaro,et al.  Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. , 1990, Investigative ophthalmology & visual science.

[5]  P. Campochiaro,et al.  Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells. , 1985, Archives of ophthalmology.

[6]  R. Machemer,et al.  Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). , 1975, American journal of ophthalmology.

[7]  E. de Juan,et al.  The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy. , 1985, American journal of ophthalmology.

[8]  P. Campochiaro,et al.  Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes , 1997, The British journal of ophthalmology.

[9]  W. Havener Massive Vitreous Retraction , 1976, International ophthalmology clinics.

[10]  R. Machemer,et al.  The classification of retinal detachment with proliferative vitreoretinopathy. , 1983, Ophthalmology.

[11]  P. Campochiaro,et al.  Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia, and fibroblasts in vitreous culture. , 1990, Investigative ophthalmology & visual science.

[12]  R. Machemer,et al.  A logical approach to the treatment of massive periretinal proliferation. , 1978, Ophthalmology.

[13]  M. Refojo,et al.  Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy. , 1995, Investigative ophthalmology & visual science.

[14]  S. Cousins,et al.  Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil. , 1994, Archives of ophthalmology.

[15]  P. Girard,et al.  CLINICAL RISK FACTORS FOR PROLIFERATIVE VITREORETINOPATHY AFTER RETINAL DETACHMENT SURGERY , 2000, Retina.

[16]  P. Campochiaro,et al.  Clinical risk factors for proliferative vitreoretinopathy. , 1989, Archives of ophthalmology.

[17]  P. Campochiaro,et al.  Growth factor responsiveness of human retinal pigment epithelial cells. , 1990, Investigative ophthalmology & visual science.

[18]  P. Campochiaro,et al.  Cryotherapy causes extensive breakdown of the blood-retinal barrier. A comparison with argon laser photocoagulation. , 1985, Archives of ophthalmology.

[19]  D. Kaiser Bacteria Also Vote , 1996, Science.

[20]  H. Kaplan,et al.  Débridement of the pig retinal pigment epithelium in vivo , 1995 .

[21]  F. Roberge,et al.  Chemotaxis of rat retinal glia to growth factors found in repairing wounds. , 1987, Investigative ophthalmology & visual science.

[22]  P. Campochiaro,et al.  A retinal pigment epithelial cell-derived growth factor(s). , 1986, Archives of ophthalmology.

[23]  P. Campochiaro,et al.  Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. , 1994, Journal of cell science.

[24]  P. Campochiaro,et al.  Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells. , 1995, Experimental eye research.

[25]  P. Campochiaro,et al.  Serum contains chemoattractants for human retinal pigment epithelial cells. , 1984, Archives of ophthalmology.

[26]  P. Campochiaro,et al.  The role of breakdown of the blood-retinal barrier in cell-injection models of proliferative vitreoretinopathy. , 1988, Archives of ophthalmology.

[27]  Gary W. Abrams,et al.  Causes of Failure After Initial Vitreoretinal Surgery for Severe Proliferative Vitreoretinopathy , 1991 .

[28]  P. Campochiaro,et al.  Retinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cells. , 1991, Investigative ophthalmology & visual science.

[29]  W. Anderson,et al.  Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene. Can proliferative vitreoretinopathy be a target of gene therapy? , 1995, Ophthalmology.

[30]  Y. Tano,et al.  Intravitreal autotransplantation of fibroblasts. , 1980, American journal of ophthalmology.

[31]  R. Adler,et al.  Apoptotic photoreceptor degeneration in experimental retinal detachment. , 1995, Investigative ophthalmology & visual science.

[32]  R. Azarnia,et al.  Autotransplantation of retinal pigment epithelium in intravitreal diffusion chamber. , 1975, American journal of ophthalmology.

[33]  D. Green,et al.  Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege , 1995, Science.

[34]  P. Campochiaro,et al.  Growth factors in the retina and retinal pigmented epithelium , 1996, Progress in Retinal and Eye Research.

[35]  P. Dirks,et al.  Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. , 1996, Critical reviews in biochemistry and molecular biology.

[36]  P. Campochiaro,et al.  Class III beta-tubulin in human retinal pigment epithelial cells in culture and in epiretinal membranes. , 1995, Experimental eye research.

[37]  T. Aaberg,et al.  AN UPDATED CLASSIFICATION OF RETINAL DETACHMENT WITH PROLIFERATIVE VITREORETINOPATHY , 1991 .

[38]  T. Aaberg,et al.  An updated classification of retinal detachment with proliferative vitreoretinopathy. , 1991, American journal of ophthalmology.

[39]  B. Matsumoto,et al.  Changes in the organization and expression of cytoskeletal proteins during retinal degeneration induced by retinal detachment. , 1995, Investigative ophthalmology & visual science.

[40]  P. Campochiaro,et al.  Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells. , 1985, Archives of ophthalmology.

[41]  K. Dutt,et al.  Vasculotropin/Vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultued in vitro , 1995, Journal of cellular physiology.

[42]  R. Machemer,et al.  Glial cell proliferation in retinal detachment (massive periretinal proliferation). , 1975, American journal of ophthalmology.

[43]  D. Anderson,et al.  The onset of pigment epithelial proliferation after retinal detachment. , 1981, Investigative ophthalmology & visual science.